Trials / Unknown
UnknownNCT03046303
Radical Gastrectomy Within Enhanced Recovery Programs(ERAS): a Prospective Randomized Controlled Trial
Radical Gastrectomy Within Enhanced Recovery Programs: a Prospective Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- The First Hospital of Jilin University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is a prospective, single-center, randomized controlled trial. The study protocol was approved by the Ethics Committee at the First Hospital of Jilin University.ERAS is combined with the laprascopic gastrectomy to assess the efficacy and safety in patients with advanced gastric carcinoma.The hospitalized patients were randomly divided into ERAS group and conventional pathway group . Inter-group differences were evaluated for clinical recovery index, economic indicators, length of hospital stay, 3 years to 5 years long-term survival, etc.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ERAS | optimized pain control, restricted I.V. fluids, early initiation of post-operative oral feeding and enforced mobilization |
Timeline
- Start date
- 2017-02-20
- Primary completion
- 2018-03-30
- Completion
- 2019-01-30
- First posted
- 2017-02-08
- Last updated
- 2017-02-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03046303. Inclusion in this directory is not an endorsement.